Source:http://linkedlifedata.com/resource/pubmed/id/21099364
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
24
|
pubmed:dateCreated |
2011-1-20
|
pubmed:abstractText |
Together, circulating BAFF and dominant receptor BAFF-R homeostatically regulate the humoral immune system. Consistently aberrant BAFF-R expression in leukemic cells reveals an intimate connection of these cells' malignant physiology to the BAFF/BAFF-R axis and also provides an additional survival mechanism to the expressing cells. In this study, we used primary cells and cell lines to interrogate the mechanisms underlying aberrant BAFF-R expression in precursor B acute lymphoblastic leukemia (precursor B-ALL) and mature B chronic lymphocytic leukemia (CLL). Here we demonstrate the aberrant expression of BAFF-R in precursor B-ALL cell lines and reveal that these cells acquire BAFF-R expression through premature transcriptional activation of the BAFF-R promoter in coordination with regulatory transcription factor c-Rel. Investigations using primary CLL cells provide a crucial counterpoint through their paucity of BAFF-R relative to their benign mature B cell counterparts, which we establish as functionally significant in its depletion of the CLL cells' BAFF-binding capacity. Furthermore, BAFF-R downregulation in CLL patients is revealed here to be restricted to the malignant compartment and mediated post-transcriptionally in order to compensate for the consistently unchanged levels of transcription factor c-Rel and BAFF-R mRNA. Finally, we present evidence that CLL cells retain endogenous mechanisms of BAFF-R regulatory control despite active receptor dysregulation.
|
pubmed:grant | |
pubmed:commentsCorrections | |
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Dec
|
pubmed:issn |
1551-4005
|
pubmed:author | |
pubmed:issnType |
Electronic
|
pubmed:day |
15
|
pubmed:volume |
9
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
4884-92
|
pubmed:meshHeading |
pubmed-meshheading:21099364-B-Cell Activating Factor,
pubmed-meshheading:21099364-B-Cell Activation Factor Receptor,
pubmed-meshheading:21099364-B-Lymphocytes,
pubmed-meshheading:21099364-Cell Line, Tumor,
pubmed-meshheading:21099364-Humans,
pubmed-meshheading:21099364-Leukemia, Lymphocytic, Chronic, B-Cell,
pubmed-meshheading:21099364-Precursor B-Cell Lymphoblastic Leukemia-Lymphoma,
pubmed-meshheading:21099364-RNA Processing, Post-Transcriptional,
pubmed-meshheading:21099364-Transcription, Genetic
|
pubmed:year |
2010
|
pubmed:articleTitle |
Transcriptional and post-transcriptional mechanisms of BAFF-receptor dysregulation in human B lineage malignancies.
|
pubmed:affiliation |
Department of Immunology, Mayo Clinic College of Medicine, Rochester, MN, USA.
|
pubmed:publicationType |
Journal Article,
Research Support, N.I.H., Extramural
|